The R&D budget for Health and Society in the US, expressed as a unit of GDP, has shown a consistent trend with minor annual variations over the period from 2013 to 2023, predominantly hovering around 0.2. Despite minor fluctuations, the value remains largely unchanged through 2023. The year-on-year variations illustrate slight declines or marginal increases over the years, indicating stability without significant growth or reduction. The last recorded 2023 value stands at 0.2, with negligible percentage changes year on year.
Key Trends:
- From 2013 to 2023, the R&D budget percentage of GDP has been generally stable with slight yearly variations.
- A consistent value of 0.2 GDP units has been maintained, with a minimal overall CAGR, highlighting steady investment levels.
- The forecast CAGRs towards 2028 indicate no substantial projected changes, suggesting continuity in the current investment approach.
Future Trends to Watch For:
- Potential shifts in policy or economic priorities that could influence the R&D budget allocation beyond current projections.
- Technological breakthroughs or public health challenges that may necessitate increased research funding.
- Global economic conditions and their impact on the allocation of GDP towards R&D in Health and Society.
